Prednimustine, mitoxantrone (PmM) vs cyclophosphamide, vincristine, prednisone (COP) for the treatment of advanced low-grade non-Hodgkin's lymphoma

Leukemia

Volumn 10, Issue 5, 1996, Pages 836-843

  Unterhalt, M ^a   Herrmann, R ^b   Tiemann, M ^c   Parwaresch, R ^c   Stein, H ^d   Trumper L ^e   Nahler, M ^f   Reuss Borst, M ^g   Tirier, C ^h   Neubauer, A ⁱ   Freund, M ^j   Kreuser, E D ⁱ   Dietzfelbinger, H ^k   Bodenstein, H ^l   Engert, A ^m   Stauder, R ⁿ   Eimermacher, H ^o   Landys, K ^p   Hiddemann, W ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

^c UNIVERSITY OF KIEL   (Germany)

^d HUMBOLDT UNIVERSITY   (Germany)

^e SAARLAND UNIVERSITY   (Germany)

^f UNIVERSITY OF MÜNSTER   (Germany)

^g UNIVERSITY OF TÜBINGEN   (Germany)

^h Evangelisches Krankhs Essen Werden ^*  (Germany)

ⁱ CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^j HANNOVER MEDICAL SCHOOL   (Germany)

^k TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^l KLINIKUM MINDEN   (Germany)

^m UNIVERSITY OF COLOGNE   (Germany)

ⁿ UNIVERSITY OF INNSBRUCK   (Austria)

^o Department of Urology   (Germany)

^p SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

more..

Author keywords

Chemotherapy; Cyclophosphamide; Low grade lymphomas; Mitoxantrone; Prednimustine

Indexed keywords

ALPHA INTERFERON; CYCLOPHOSPHAMIDE; MITOXANTRONE; PREDNIMUSTINE; PREDNISONE; VINCRISTINE;

ADULT; ADVANCED CANCER; AGED; ALOPECIA; ANTINEOPLASTIC ACTIVITY; ARTICLE; BONE MARROW SUPPRESSION; CANCER COMBINATION CHEMOTHERAPY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; GRANULOCYTOPENIA; HAIR LOSS; HUMAN; LEUKEMIA REMISSION; MAJOR CLINICAL STUDY; MULTICENTER STUDY; NAUSEA; NEUROTOXICITY; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; VOMITING;

EID: 9344248368     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Horning SJ. Treatment approaches to the low-grade lymphomas. Blood 1994; 83: 881-884.
2. Hiddemann W, Unterhalt M. Current status and future perspectives in the treatment of low-grade non-Hodgkin's lymphomas. Blood Cell Rev 1994; 8: 225-233.
3. Rohatiner AZS, Johnson PWM, Price CGA et al. Myeloablative therapy with autologous bone marrow transplantation as consolidation therapy for recurrent follicular lymphoma. J Clin Oncol 1994; 12: 1177-1184.
4. Armitage JO, Treatment of non-Hodgkin's lymphoma. New Engl J Med 1992; 328: 1023-1030.
5. Longo D. What's the deal with follicular lymphomas? J Clin Oncol 1993; 11: 202-208.
6. Rohatiner A, Lister TA. Management of follicular lymphoma. Curr Opin Oncol 1994; 6: 473-479.
7. Gribben JG, Saporito L, Barber M et al. Bone marrows of non-Hogkin's lymphoma patients with a bcl-2 translocation can be purged of polymerase chain reaction-detectable lymphoma cells using monoclonal antibodies and immunomagnetic bead depletion. Blood 1992; 80: 1083-1089.
8. Vose JM, Anderson JR, Kessinger A et at. High-dose chemotherapy and autologous hematopoietic stem-cell transplantation for aggressive non-Hodgkin's lymphoma. I Clin Oncol 1993: 11: 1846-1851.
9. Schouten HC, Colombat PH, Verdonck LF et al. Autologous bone marrow transplantation for low-grade non-Hodgkin's lymphoma: the European Bone Marrow Transplant Group experience. Ann Oncol 1994; 5 (Suppl 2): 147-149.
10. Colombat PH, Donadio D, Fouillard L et al. Value of autologous bone marrow transplantation in follicular lymphoma: a France Autogreffe retrospective study of 42 patients. Bone Marrow Transplant 1994; 13: 157-162.
11. Landys KE. Novantrone in combination with sterecyte (NOSTE) in treatment of unfavourable non-Hodgkin's lymphoma. New Drugs 1988; 6: 105-113.
12. Hiddemann W, Unterhalt M, Koch P et al. Treatment of low-grade non-Hodgkin's lymphoma by cytoreductive chemotherapy with prednimustine/mitoxantrone followed by Interferon α-2b maintenance: results of a clinical phase II study. Semin Oncol 1990; 6 (Suppl. 10): 20-23.
13. Hiddemann W, Unterhalt M. New aspects in the treatment of advanced low-grade non-Hodgkin's lymphomas: prednimustine/ mitoxantrone (PmM) vs cyclophosphamide/vincristine/prednisone (COP) followed by Interferon α vs observation only - a preliminary update of the German Low-Grade Lymphoma Study Group. Semin Hematol 1994; 31 (Suppl. 3): 32-35.
14. Bagley CM, DeVita VT, Berard CW et al. Advanced lymphomsarcoma: intensive cyclical combination chemotherapy with cyclophosphamide, vincristine and prednisone. Ann Intern Meet 1972; 76: 227-234.
15. Hoppe RT. The role of radiation therapy in the management of the non-Hodgkin's lymphomas. Cancer 1985; 55: 2176-2183.
16. Steward WP, Crowther D, McWilliam LJ et al. Maintenance chlorambucil after CVP in the management of advanced stage, lowgrade histologic type non-Hodgkin's lymphoma. Cancer 1988; 61: 441-447.
17. Lister TA. The management of follicular lymphoma. Ann Oncol 1991; 2 (Suppl. 2): 131-135.
18. Stansfeld AG, Diebold J, Kanci Y et al. Updated Kiel classification for lymphomas. Lancet 1988; 603: 292-293.
19. Lennert K, Feller AC. Histopathology of non-Hodgkin's Lymphomas (Based on the Updated Kiel Classification). Springer: Berlin, 1992.
20. Harris NL, Jaffe ES, Stein H et al. A proposal for an international consensus on the classification of lymphoid neoplasms. Blood 1994; 84: 1361-1392.
21. Whitehead J. The Design and Analysis of Sequential Clinical Trials (second edition). Ellis Horwood: New York, 1992.
22. Hagenbeek A, Carde P, Somers R et al. Maintenance of remission with human recombinant alpha-2 interferon (Roferon-A) in patients with stages III and IV low-grade malignant non-Hodgkin's lymphoma. Results from a prospective, randomised phase III clinical trial in 331 patients. Blood 1992; 80 (Suppl. 1): 74a.
23. Cavallin-Stahl E, Möller TR. Prednimustine vs cyclophosphamidevincristine-prednisolone in the treatment of non-Hodgkin's lymphorna with favorable histopathology: results of a National Cancer Care Program in Sweden. Semin Oncol 1986; 13 (Suppl. 1): 19-22.
24. Smalley RV, Andersen JW, Hawkins MJ et al. Interferon alfa combined with cytotoxic chemotherapy for patients with non-Hodgkin's lymphoma. New Engl J Med 1992; 19: 1336-1341.
25. Solal-Celigny P, Lepage E, Brousse N et al. Recombinant interferon alfa-2b combined with a regimen containing doxorubicin in patients with advanced follicular lymphoma. New Engl J Med 1993; 22: 1608-1614.
26. Chisesi T, Congiu M, Contu A et al. Randomized study of chlorambucil (CB) compared to interferon (alfa-2b) combined with CB in low-grade non-Hodgkin's lymphoma: an interim report of a randomized study. Eur J Cancer 1991; 27 (Suppl. 4): 31-33.
27. Price CGA, Rohatiner AZS, Steward W et al. Interferon α2b in the treatment of follicular lymphoma: preliminary results of a trial in progress. Ann Oncol 1991; 2 (Suppl. 2): 141-145.
28. Peterson BA, Petroni G, Oken MM et al. Cyclophosphamide vs cyclophosphamide plus interferon alfa-2b in follicular low-grade lymphomas: a preliminary report of an intergroup trial (CALGB 8691 and EST 7486). Proc Am Soc Clin Oncol 1993; 12: 366.